Clinical Trials Search at Vanderbilt-Ingram Cancer Center

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

Multiple Cancer Types

The LCH-IV is an international, multicenter, prospective clinical study for pediatric
Langerhans Cell Histiocytosis LCH (age < 18 years).

Disease Sites: Miscellaneous, Pediatrics

Phase: III

Investigator: Pastakia, Devang

NCTID: NCT02205762

Protocol No: VICCPED2231

Infectious Disease Outcomes in Pediatric Oncology Patients

Multiple Cancer Types

Disease Sites: Miscellaneous, Pediatrics

Phase: N/A

Investigator: Esbenshade, Adam

NCTID:

Protocol No: VICCPED14127

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form